We use cookies to give you the best possible experience on our website. By continuing to browse this site, you give consent for cookies to be used. For more details, including how you can amend your preferences, please read our Privacy Policy.
Respiratory care
At ResMed, we provide a number of solutions to treat respiratory disorders.
Noninvasive ventilation (NIV) has often been used to treat patients with respiratory dysfunction. Some immediate benefits of NIV include a relief in symptoms of fatigue, daytime sleepiness and morning headaches. Noninvasive ventilation can also improve daytime gas exchange and quality of life, and also reduced hospitalisation time.
Find out how noninvasive ventilation and ResMed treatment can benefit specific patients below.
Noninvasive ventilation for COPD patients
Treatment of COPD with noninvasive ventilation (NIV) has been shown to be effective in treating acute exacerbations of COPD, assisting pulmonary rehabilitation in COPD patients, and providing benefits in managing chronic hypercapnic COPD patients.
Non-invasive ventilation for obesity hypoventilation syndrome
Non-invasive ventilation in patients with obesity hypoventilation syndrome has been shown to normalise blood gases, prolong survival and increase exercise capacity.
Non-invasive ventilation for acute respiratory failure
Non-invasive ventilation (NIV) is often used for patients with Chronic Obstructive Pulmonary Disease, but emerging evidence suggests that NIV can be used in treating other types of acute respiratory failure.
Non-invasive ventilation for paediatric patients
Children with inherited neuromuscular conditions have a high risk of respiratory disorders during early childhood or adolescence. Noninvasive ventilation is recommended to improve quality of life.
Non-invasive ventilation for neuromuscular diseases in adults
Many chronic neuromuscular disorders lead to progressive respiratory muscle dysfunction. Non-invasive ventilation can help reduce daytime sleepiness while facilitating gas exchange and breathing.